0
Your cart

Your cart is empty

Books > Medicine > General issues > Public health & preventive medicine > Epidemiology & medical statistics

Buy Now

Simultaneous Global New Drug Development - Multi-Regional Clinical Trials after ICH E17 (Hardcover) Loot Price: R4,319
Discovery Miles 43 190
Simultaneous Global New Drug Development - Multi-Regional Clinical Trials after ICH E17 (Hardcover): Gang Li, Bruce Binkowitz,...

Simultaneous Global New Drug Development - Multi-Regional Clinical Trials after ICH E17 (Hardcover)

Gang Li, Bruce Binkowitz, William Wang, Hui Quan, Josh Chen

Series: Chapman & Hall/CRC Biostatistics Series

 (sign in to rate)
Loot Price R4,319 Discovery Miles 43 190 | Repayment Terms: R405 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Global simultaneous development is becoming more necessary as the cost of developing medical products continues to grow. The strategy of using multiregional clinical trials (MRCTs) has become the preferred method for developing new medicines. Implementing the same protocol to include subjects from many geographical regions around the world, MRCTs can speed up the patient enrolment, thus resulting in quicker drug development and obtaining faster approval of the drug globally. After the publication of the editors' first volume on this topic, there have been new developments on MRCTs. The International Council for Harmonisation (ICH) issued ICH E17, a guideline document on MRCTs, in November 2017, laying out principles on MRCTs. Beyond E17, new methodologies have been developed as well. Simultaneous Global New Drug Development: Multi-Regional Clinical Trials after ICH E17 collects chapters providing interpretations of principles in ICH E17 and new ideas of implementing MRCTs. Authors are from different regions, and from academia and industry. In addition, in contrast to the first book, new perspectives are brought to MRCT from regulatory agencies. This book will be of particular interest to biostatisticians working in late stage clinical development of medical products. It will also be especially helpful for statisticians in regulatory agencies, and medical research institutes. This book is comprehensive across the MRCT topic spectrum, including Issues regarding ICH E17 Implementation MRCT Design and Analysis Methodologies Perspectives from authorities in regulatory agencies, as well as statisticians practicing in the medical product industry Many examples of real-life applications based on actual MRCTs.

General

Imprint: Crc Press
Country of origin: United Kingdom
Series: Chapman & Hall/CRC Biostatistics Series
Release date: December 2021
First published: 2022
Editors: Gang Li • Bruce Binkowitz • William Wang • Hui Quan • Josh Chen
Dimensions: 234 x 156 x 27mm (L x W x T)
Format: Hardcover
Pages: 302
ISBN-13: 978-0-367-56560-2
Categories: Books > Science & Mathematics > Mathematics > Probability & statistics
Books > Medicine > General issues > Medical equipment & techniques > Medical research
Books > Medicine > General issues > Public health & preventive medicine > Epidemiology & medical statistics
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN: 0-367-56560-9
Barcode: 9780367565602

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners